These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11409123

  • 1. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
    Mudano A, Allison J, Hill J, Rothermel T, Saag K.
    J Rheumatol; 2001 Jun; 28(6):1298-305. PubMed ID: 11409123
    [Abstract] [Full Text] [Related]

  • 2. Trends in prevention of glucocorticoid-induced osteoporosis.
    Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL.
    J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
    [Abstract] [Full Text] [Related]

  • 3. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG.
    Arch Intern Med; 2007 Mar 26; 167(6):591-6. PubMed ID: 17389291
    [Abstract] [Full Text] [Related]

  • 4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul 26; 44(7):1496-503. PubMed ID: 11465699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec 26; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN.
    Minerva Med; 2008 Feb 26; 99(1):23-43. PubMed ID: 18299694
    [Abstract] [Full Text] [Related]

  • 9. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.
    Yood RA, Harrold LR, Fish L, Cernieux J, Emani S, Conboy E, Gurwitz JH.
    Arch Intern Med; 2001 May 28; 161(10):1322-7. PubMed ID: 11371261
    [Abstract] [Full Text] [Related]

  • 10. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
    Tanvetyanon T.
    Cancer; 2005 Jan 15; 103(2):237-41. PubMed ID: 15597384
    [Abstract] [Full Text] [Related]

  • 11. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct 15; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 12. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis.
    Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD.
    J Rheumatol; 2004 Mar 15; 31(3):550-6. PubMed ID: 14994404
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
    Zink A, Listing J, Ziemer S, Zeidler H, German Collaborative Arthritis Centres.
    J Rheumatol; 2001 Oct 15; 28(10):2201-8. PubMed ID: 11669156
    [Abstract] [Full Text] [Related]

  • 16. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
    Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD.
    J Clin Endocrinol Metab; 2012 Apr 15; 97(4):1236-42. PubMed ID: 22298803
    [Abstract] [Full Text] [Related]

  • 17. Prescribing for osteoporosis following the use of inhaled and oral glucocorticoids in general practice.
    Williams D, Bennett K, Feely J.
    Br J Clin Pharmacol; 2004 Dec 15; 58(6):665-72. PubMed ID: 15563364
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
    Cruse LM, Valeriano J, Vasey FB, Carter JD.
    J Clin Rheumatol; 2006 Oct 15; 12(5):221-5. PubMed ID: 17023807
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
    Ettinger B, Chidambaran P, Pressman A.
    Am J Manag Care; 2001 Jun 15; 7(6):597-605. PubMed ID: 11439733
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.